Holt S E, Wright W E, Shay J W
Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Center, Dallas 75235-9039, USA.
Mol Cell Biol. 1996 Jun;16(6):2932-9. doi: 10.1128/MCB.16.6.2932.
Telomerase is a ribonucleoprotein whose activity has been detected in germ line cells, immortal cells, and most cancer cells. Except in stem cells, which have a low level of telomerase activity, its activity is absent from normal somatic tissues. Understanding the regulation of telomerase activity is critical for the development of potential tools for the diagnosis and treatment of cancer. Using the telomeric repeat amplification protocol, we found that immortal, telomerase-positive, pseudodiploid human cells (HT1080 and HL60 cells) sorted by flow repressed in quiescent cells. This was true whether quiescence was induced by contact inhibition (NIH 3T3 mouse cells), growth factor removal (bromodeoxyuridine-blocked mouse myoblasts), reexpression of cellular senescence (the reversibly immortalized IDH4 cells), or irreversible cell differentiation (HL60 promyelocytic leukemia cells and C2C12 mouse myoblasts). Taken together, these results indicate that telomerase is active throughout the cell in dividing, immortal cells but that its activity is repressed in cells that exit the cell cycle. This suggests that quiescent stem cells that have the potential to express telomerase may remain unaffected by potential antitelomerase cancer therapies.
端粒酶是一种核糖核蛋白,其活性已在生殖系细胞、永生化细胞和大多数癌细胞中被检测到。除了在具有低水平端粒酶活性的干细胞中,正常体细胞组织中不存在其活性。了解端粒酶活性的调节对于开发癌症诊断和治疗的潜在工具至关重要。使用端粒重复序列扩增协议,我们发现通过流式细胞术分选的永生化、端粒酶阳性、假二倍体人类细胞(HT1080和HL60细胞)在静止细胞中受到抑制。无论静止是由接触抑制(NIH 3T3小鼠细胞)、生长因子去除(溴脱氧尿苷阻断的小鼠成肌细胞)、细胞衰老的重新表达(可逆性永生化的IDH4细胞)还是不可逆的细胞分化(HL60早幼粒细胞白血病细胞和C2C12小鼠成肌细胞)诱导,都是如此。综上所述,这些结果表明端粒酶在分裂的永生化细胞的整个细胞中是活跃的,但在退出细胞周期的细胞中其活性受到抑制。这表明有可能表达端粒酶的静止干细胞可能不受潜在的抗端粒酶癌症治疗的影响。